Pharma & Biotech

Eli Lilly's ambitious push into artificial intelligence is generating significant excitement across Wall Street. The pharmaceutical giant's recent alliance with...

The financial outlook for Ocugen has grown increasingly precarious, with the biotechnology firm's stock extending losses for five consecutive trading...

Corcept Therapeutics shares have experienced significant volatility in recent trading sessions, creating both concern and opportunity for investors. The biopharmaceutical...

Vivani Medical (Vivani Med.inc.ew) enters a pivotal week as investors await Tuesday's quarterly earnings release. Market expectations point toward a...

The investment community is watching closely as Stereotaxis, a pioneer in robotic medical technology, prepares to release its quarterly earnings....

A severe clinical setback has triggered a massive sell-off in Intellia Therapeutics stock, with shares plummeting more than 22% during...

The shares of Canadian artificial intelligence specialist Healwell AI are attracting significant market attention following a period of transformative corporate...

BioNTech's equity performance is presenting a conundrum for market participants. The company continues to deliver impressive revenue figures and has...

A recent decision by the European Patent Office has positioned BioNxt Solutions for a potential breakthrough in multiple sclerosis treatment....

CureVac investors face a pivotal moment as BioNTech's acquisition proposal moves toward a decisive shareholder vote. The extraordinary general meeting...